Aridis Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2017 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aridis Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2017 to Q3 2023.
  • Aridis Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $200K, a 42.7% decline year-over-year.
  • Aridis Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $862K, a 52.7% decline year-over-year.
  • Aridis Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.48M, a 34.3% decline from 2021.
  • Aridis Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.25M, a 5.78% increase from 2020.
  • Aridis Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $2.13M, a 10.4% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $862K $200K -$149K -42.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $1.01M $210K -$246K -53.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-09-14
Q1 2023 $1.26M $245K -$222K -47.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-06-08
Q4 2022 $1.48M $207K -$344K -62.4% Oct 1, 2022 Dec 31, 2022 10-K 2023-05-22
Q3 2022 $1.82M $349K -$231K -39.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $2.05M $456K -$97K -17.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-09-14
Q1 2022 $2.15M $467K -$100K -17.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-06-08
Q4 2021 $2.25M $551K -$15K -2.65% Oct 1, 2021 Dec 31, 2021 10-K 2023-05-22
Q3 2021 $2.27M $580K +$18K +3.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 $2.25M $553K +$30K +5.74% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-16
Q1 2021 $2.22M $567K +$90K +18.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $2.13M $566K +$77K +15.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-13
Q3 2020 $2.05M $562K +$43K +8.29% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $2.01M $523K +$20K +3.98% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $1.99M $477K +$60K +14.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $1.93M $489K +$146K +42.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 $1.78M $519K +$125K +31.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-23
Q2 2019 $1.66M $503K +$185K +58.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $1.47M $417K -$54K -11.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $1.53M $343K Oct 1, 2018 Dec 31, 2018 10-K 2020-04-08
Q3 2018 $394K +$191K +94.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $318K -$39K -10.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $471K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q3 2017 $203K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $357K Apr 1, 2017 Jun 30, 2017 10-Q 2018-09-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.